Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000326269 | SCV000351499 | uncertain significance | Steroid-resistant nephrotic syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001492620 | SCV001697236 | likely benign | not provided | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000326269 | SCV001464471 | uncertain significance | Steroid-resistant nephrotic syndrome | 2020-04-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003940095 | SCV004753504 | likely benign | NPHS2-related disorder | 2019-12-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |